Metropolitan Life Insurance Company (MetLife)’s Centene CNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-21,556
Closed -$1.69M 460
2024
Q1
$1.69M Sell
21,556
-188
-0.9% -$14.5K 0.07% 231
2023
Q4
$1.61M Sell
21,744
-659
-3% -$47.5K 0.08% 219
2023
Q3
$1.54M Sell
22,403
-1,511
-6% -$101K 0.08% 214
2023
Q2
$1.61M Sell
23,914
-719
-3% -$47.9K 0.08% 228
2023
Q1
$1.56M Sell
24,633
-8,118
-25% -$576K 0.08% 229
2022
Q4
$2.69M Sell
32,751
-1,277
-4% -$104K 0.12% 168
2022
Q3
$2.65M Sell
34,028
-1,200
-3% -$107K 0.13% 156
2022
Q2
$2.98M Sell
35,228
-781
-2% -$64.9K 0.13% 153
2022
Q1
$3.03M Sell
36,009
-30,591
-46% -$2.51M 0.11% 178
2021
Q4
$5.49M Sell
66,600
-1,889
-3% -$138K 0.07% 209
2021
Q3
$4.27M Sell
68,489
-2,294
-3% -$153K 0.06% 248
2021
Q2
$5.16M Sell
70,783
-9,810
-12% -$672K 0.07% 210
2021
Q1
$5.15M Sell
80,593
-4,039
-5% -$250K 0.08% 201
2020
Q4
$5.08M Sell
84,632
-4,106
-5% -$261K 0.08% 201
2020
Q3
$5.18M Sell
88,738
-3,744
-4% -$233K 0.09% 180
2020
Q2
$5.88M Sell
92,482
-18,427
-17% -$1.2M 0.1% 157
2020
Q1
$6.59M Buy
110,909
+31,736
+40% +$1.93M 0.14% 141
2019
Q4
$4.98M Sell
79,173
-317
-0.4% -$17.2K 0.08% 212
2019
Q3
$3.44M Sell
79,490
-512
-0.6% -$24.9K 0.06% 289
2019
Q2
$4.2M Buy
80,002
+3,344
+4% +$181K 0.07% 240
2019
Q1
$4.07M Sell
76,658
-1,698
-2% -$103K 0.07% 223
2018
Q4
$4.52M Buy
78,356
+814
+1% +$54.5K 0.09% 188
2018
Q3
$5.61M Sell
77,542
-1,878
-2% -$130K 0.1% 180
2018
Q2
$4.89M Buy
79,420
+24,576
+45% +$1.42M 0.08% 213
2018
Q1
$2.93M Buy
54,844
+568
+1% +$29.6K 0.04% 334
2017
Q4
$2.74M Sell
54,276
-111,318
-67% -$5.39M 0.04% 361
2017
Q3
$8.01M Sell
165,594
-3,258
-2% -$140K 0.05% 332
2017
Q2
$6.74M Sell
168,852
-11,986
-7% -$452K 0.05% 399
2017
Q1
$6.44M Sell
180,838
-1,572
-0.9% -$52.6K 0.04% 430
2016
Q4
$5.15M Sell
182,410
-2,828
-2% -$83.4K 0.04% 551
2016
Q3
$6.2M Sell
185,238
-1,794
-1% -$62.3K 0.05% 416
2016
Q2
$6.67M Sell
187,032
-1,610
-0.9% -$50.6K 0.05% 375
2016
Q1
$5.81M Sell
188,642
-32,192
-15% -$961K 0.04% 434
2015
Q4
$7.27M Buy
220,834
+1,528
+0.7% +$45.3K 0.06% 327
2015
Q3
$5.95M Sell
219,306
-1,528
-0.7% -$51.1K 0.04% 422
2015
Q2
$8.88M Buy
220,834
+2,270
+1% +$81.5K 0.06% 299
2015
Q1
$7.72M Buy
218,564
+9,688
+5% +$291K 0.06% 340
2014
Q4
$5.42M Buy
208,876
+2,444
+1% +$57K 0.04% 502
2014
Q3
$4.27M Buy
206,432
+190,484
+1,194% +$3.67M 0.03% 584
2014
Q2
$301K Sell
15,948
-158,296
-91% -$2.72M ﹤0.01% 2201
2014
Q1
$2.71M Sell
174,244
-628
-0.4% -$9.72K 0.02% 827
2013
Q4
$2.58M Buy
174,872
+3,876
+2% +$58K 0.02% 842
2013
Q3
$2.73M Sell
170,996
-564
-0.3% -$8.12K 0.02% 771
2013
Q2
$2.25M Buy
+171,560
New +$2.08M 0.02% 822

Other funds holding CNC

Metropolitan Life Insurance Company (MetLife)'s CNC Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Centene (CNC) in Q2 2024, closing a stake of 21,556 shares — an estimated $1.69M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CNC in Q2 2013 and held it in 44 quarters. The position peaked at $8.88M in Q2 2015. 896 funds tracked by Wall St. Rank hold CNC as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Centene position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 21,556 Centene shares in Q2 2024, an estimated $1.69M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Centene in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Centene position peaked at $8.88M in Q2 2015.
  • 896 funds tracked by Wall St. Rank held Centene as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.